HK:1228 Stock Latest News
Company AnnouncementsCANbridge’s Gaurunning and Livmarli Included in Commercial Insurance Cost Table3d ago1228
Company AnnouncementsCANbridge boosts rare disease footprint after HK$200 million WuXi stake2M ago1228
Company AnnouncementsCANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli3M ago1228
Company AnnouncementsCANbridge sets August board meeting to approve 2026 interim results3M ago1228
Company AnnouncementsCANbridge Pharmaceuticals Refreshes Board and Committee Leadership With New Independent Director3M ago1228
Company AnnouncementsCANbridge Pharmaceuticals Details Board and Committee Structure3M ago1228Company AnnouncementsCANbridge Shareholders Unanimously Approve WuXi Biologics Service Agreement3M ago1228
Company AnnouncementsCANbridge Advances North African Expansion for Gaucher Drug Gaurunning3M ago1228
Company AnnouncementsCANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework4M ago1228
Company AnnouncementsCANbridge delays shareholder circular on WuXi Biologics framework deal4M ago1228
Company AnnouncementsCANbridge Shareholders Approve All Resolutions at 2026 AGM4M ago1228
Company AnnouncementsCANbridge Sets New Connected Service Deals With WuXi Biologics and Baheal Medical5M ago1228
Company AnnouncementsCANbridge Sets 2026 Virtual AGM, Seeks Share Issuance Mandate Renewal5M ago1228Company AnnouncementsCANbridge Ties CEO Equity Award to Licensing Milestones and Sales Growth7M ago1228
Company AnnouncementsCANbridge Reshuffles Key Company Secretary and Compliance Roles After Resignation7M ago1228
Company AnnouncementsCANbridge deepens Baheal alliance as rare-disease drugs gain regulatory and insurance momentum in China7M ago1228
Company AnnouncementsCANbridge Pharmaceuticals Schedules Board Meeting to Approve 2025 Annual Results8M ago1228
Company AnnouncementsCANbridge Flags WuXi License Deals as Connected Transactions After New Major Shareholder Entry8M ago1228
Company AnnouncementsCANbridge Completes HK$2.38 New Share Subscription, Reshaping Shareholder Base8M ago1228
Company AnnouncementsCANbridge Clarifies Equity Grants to Key R&D and Regulatory Advisers9M ago1228Company AnnouncementsCANbridge to Raise HK$199 Million via Discounted Share Subscription Backed by WuXi Biologics Unit9M ago1228
Company AnnouncementsCANbridge Grants Share Options and RSUs Equal to 1.25% of Share Capital10M ago1228

